A Study to Test New Investigational Drugs (LCFA-01and LC103) for Bacterial Vaginosis (BV) Treatment

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This Phase 1b study will evaluate different combinations of LCFA-01, LC103, and the antibiotic metronidazole in women with bacterial vaginosis (BV). Participants will be randomly assigned to one of five treatment groups and followed for approximately 13 weeks to assess the safety of the treatments, how well they work to treat BV, and their effects on the vaginal microbiome. Up to 280 participants will be enrolled in this study
Epistemonikos ID: 2cc16a1e9e4799d48fad771d481385c8872b0959
First added on: Oct 16, 2026